Literature DB >> 33624572

Cancer survivor worries about treatment disruption and detrimental health outcomes due to the COVID-19 pandemic.

Corinne R Leach1, Elizabeth G Kirkland1, Matt Masters1, Kirsten Sloan2, Erika Rees-Punia1, Alpa V Patel1, Lesley Watson3,4.   

Abstract

PURPOSE: We examined cancer survivor worries about treatment, infection, and finances early in the U.S. COVID-19 pandemic.
DESIGN: Closed- and open-ended online survey questions were collected from adult cancer survivors (N = 972).
METHODS: Logistic regression identified factors associated with treatment, infection, and financial worry. Thematic qualitative analysis generated information around participants' experiences and worries related to COVID-19 and healthcare.
FINDINGS: Characteristics including marital status, race/ethnicity, cancer type, time since last treatment, education, and age were associated with health and healthcare worry outcomes. Survivors commonly expressed uncertainty about future care, fears about in-person appointments, rationed COVID-19 care, recurrence due to care delays, and distress about untreated symptoms, including mental health issues.
CONCLUSIONS: Early in the pandemic, survivors worried about and experienced cancer care delays, COVID infection, and how the pandemic would affect their prognosis. IMPLICATIONS: Healthcare professionals need to be aware of cancer survivors' concerns and uncertainties to provide appropriate care.

Entities:  

Keywords:  COVID-19; anxiety/depression; cancer; fear; financial; survivorship; worry

Mesh:

Year:  2021        PMID: 33624572     DOI: 10.1080/07347332.2021.1888184

Source DB:  PubMed          Journal:  J Psychosoc Oncol        ISSN: 0734-7332


  8 in total

Review 1.  Counting the social, psychological, and economic costs of COVID-19 for cancer patients.

Authors:  Ann Kirby; Frances J Drummond; Amy Lawlor; Aileen Murphy
Journal:  Support Care Cancer       Date:  2022-06-11       Impact factor: 3.359

2.  Patients' Experiences with Cancer Care: Impact of the COVID-19 Pandemic.

Authors:  Katherine Treiman; Elissa C Kranzler; Rebecca Moultrie; Laura Arena; Nicole Mack; Erica Fortune; Reese Garcia; Richard L Street
Journal:  J Patient Exp       Date:  2022-04-21

3.  Stressors and Other Pandemic-related Predictors of Prospective Changes in Psychological Distress.

Authors:  Corinne R Leach; Erika Rees-Punia; Christina C Newton; Sicha Chantaprasopsuk; Alpa V Patel; J Lee Westmaas
Journal:  Lancet Reg Health Am       Date:  2021-09-09

4.  Experiences and needs of people with haematological cancers during the COVID-19 pandemic: A qualitative study.

Authors:  Nienke Zomerdijk; Michelle Jongenelis; Eva Yuen; Jane Turner; Kathryn Huntley; Andrew Smith; Megan McIntosh; Camille E Short
Journal:  Psychooncology       Date:  2021-09-09       Impact factor: 3.955

5.  COVID-19 and access to cancer care in Kenya: patient perspective.

Authors:  Shahid Umar; Andriy Chybisov; Kristie McComb; Catherine Nyongesa; Christine Mugo-Sitati; Anastacia Bosire; Charles Muya; Corinne R Leach
Journal:  Int J Cancer       Date:  2022-01-07       Impact factor: 7.316

Review 6.  The psychosocial and emotional experiences of cancer patients during the COVID-19 pandemic: A systematic review.

Authors:  A Muls; S Georgopoulou; E Hainsworth; B Hartley; G O'Gara; S Stapleton; S Cruickshank
Journal:  Semin Oncol       Date:  2022-08-22       Impact factor: 5.385

7.  The first year of the COVID-19 pandemic and health among cancer survivors in the United States.

Authors:  Xuesong Han; Sylvia Kewei Shi; Jingxuan Zhao; Leticia M Nogueira; Priti Bandi; Stacey A Fedewa; Ahmedin Jemal; K Robin Yabroff
Journal:  Cancer       Date:  2022-08-22       Impact factor: 6.921

8.  Prevalence and correlates of psychological distress, unmet supportive care needs, and fear of cancer recurrence among haematological cancer patients during the COVID-19 pandemic.

Authors:  Nienke Zomerdijk; Michelle Jongenelis; Camille E Short; Andrew Smith; Jane Turner; Kathryn Huntley
Journal:  Support Care Cancer       Date:  2021-06-23       Impact factor: 3.603

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.